mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.0074 |
0.9 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |